Cell Painting in High‑Content Screening: Limitations and the Rise of Fluorescent Ligands as a Scalable Alternative

High-content screening (HCS) has rapidly emerged as a powerful tool in drug discovery, enabling the detailed and quantitative analysis of cell states through high-throughput imaging. Among its most popular tools, the cell painting technique has become a standard for morphological profiling, creating multidimensional datasets that help decipher both compound mechanisms and off-target effects. Yet as throughput, reproducibility, and cost pressures rise, its constraints are becoming more visible, and alternative strategies, notably the use of fluorescent ligands, are gaining traction. In this article, we compare both approaches, explore where cell painting falls short in large campaigns, and argue why ligand-based HCS may deliver a more streamlined path to actionable data.

What Is Cell Painting and How Is It Used in High‑Content Screening?

The cell painting assay is a multiplexed morphological profiling method in which cells are stained with multiple fluorescent dyes that highlight subcellular compartments (nucleus, actin, endoplasmic reticulum, mitochondria, Golgi, etc.). After staining and fixation, images are acquired in multiple channels, and computational pipelines extract hundreds to thousands of morphological features per cell (size, texture, intensity, granularity, adjacency metrics). The resulting high-dimensional “phenotypic fingerprint” can be compared across chemical or genetic perturbations to infer similarities, mechanisms of action, and phenotypic clustering. Recent reviews have updated the deployment of cell painting across screening assays, its integration with machine learning, and improvements in batch correction.

In practice, cell painting workflows are often used in image-based phenotypic screening campaigns to classify compounds, discover off-target effects, or map perturbation landscapes in an unbiased manner. Its appeal lies in being broadly agnostic to preselected biomarkers: one experiment yields a rich multiparametric dataset that can be mined for many phenotypes rather than a single endpoint.

Figure 1. Sample images of U2OS-labeled cellular components. Adapted from: Pearson YE, Kremb S, Butterfoss GL, Xie X, Fahs H, Gunsalus KC. A statistical framework for high-content phenotypic profiling using cellular feature distributions. Commun Biol. 2022 Dec 22;5(1):1409. 

How Much Can Cell Painting Really Tell Us? Morphological Profiling and Its Limits

While cell painting has proven compelling, its capacity to resolve mechanistic nuances has limits. Some key constraints include:

• Spectral overlap and marker constraints: Only a limited number of stains can be multiplexed, usually 4-5, due to fluorescence channel overlap. This often forces us to “share” channels for distinct organelles (e.g., actin and Golgi), reducing profiling specificity and complicating image analysis.

• Cell-type and biological process bias: Some pathways or targets may not generate detectable morphological changes, making them invisible to standard cell painting technique analysis, even with the latest dyes.​

• Batch effects and normalization difficulties: Even small shifts in cell seeding, fixation, or plate handling can introduce artifacts that mask genuine biological signals, especially across large screening campaigns.​

• Computational complexity: High-dimensional datasets generated by image-based phenotypic screening are hard to analyze, leading to risks of overfitting or spurious associations without robust statistical controls.​

• Gene-targeting artifacts: RNAi-based morphological screens may be confounded by off-target effects, complicating downstream interpretation for gene function studies.

These limitations do not negate the value of morphological profiling, but they highlight why cell painting may struggle when scaling to large compound libraries, tight decision timelines, or mechanistic profiling end goals.

Challenges in Scaling Cell Painting Assays: Cost, Complexity, and Reproducibility

Large-scale cell painting assays introduce significant challenges that can limit their practicality when we seek rapid, reproducible results:​

• Costs: The need for large quantities of proprietary dyes elevates the assay price.

• Complex and variable staining protocols: Each cell painting assay involves multiple fluorescent dyes, fixation, and wash steps. Small deviations in incubation time, reagent quality, or plate handling can significantly compromise reproducibility.
  
• Spectral overlap and imaging design constraints: Using six or more dyes pushes the limits of microscopy-based high content screening, where emission spectra often overlap.
  
• Ambiguous signal interpretation: Morphological readouts integrate information from several organelles, making it difficult to pinpoint whether a phenotype arises from a direct molecular effect or secondary stress response. Even advanced high-content screening software struggles to fully disentangle these mixed signatures.
  
• High data and storage burden: A single cell painting assay can generate millions of images and thousands of features per plate. This imposes heavy demands on storage, computation, and curation pipelines, slowing feedback loops and data integration across studies.
  
• Limited assay flexibility: Once a staining panel is validated, adapting it to new targets or pathways requires extensive re-optimization, reducing agility for iterative high-content screening in drug discovery campaigns.

These factors make cell painting in high content screening less suited for scalable or time-sensitive screening programs. In contrast, streamlined imaging workflows using fluorescent ligands can provide direct, reproducible readouts with faster turnaround and lower operational complexity.

Fluorescent Ligands vs. Cell Painting: A More Streamlined Path to High‑Content Data

Fluorescent ligands represent a leap forward in specificity, scalability, and real-time analysis for microscopy-based high-content screening. Unlike multi-dye cell painting assays, these probes are designed to bind selectively to defined targets, such as G protein-coupled receptors, kinases, or cell-surface biomarkers, enabling exquisitely sensitive detection with minimal spectral overlap.​

Key advantages over classic cell painting:

• Streamlined multiplexed fluorescence imaging: Modern ligand chemistry permits multiple probe labeling with minimal crosstalk, reducing the need for complex unmixing and image processing.​

• Lower reagent and instrument costs: Targeted probes are often used at lower concentrations and require fewer imaging channels, lowering both per-sample costs and hardware complexity.

• Improved data interpretability: Direct, high-fidelity readouts boost confidence in target engagement, functional analysis, and early structure-activity relationship studies.

• Live-cell compatibility: Fluorescent ligands can be used in true live-cell protocols, facilitating kinetic and longitudinal analyses that would be impossible with traditional cell painting.​

• Rapid scaling: Optimized workflows can dramatically accelerate the rate of high-throughput screening assays, with cleaner, more reproducible signals.

When coupled with high-content analysis system platforms and custom analysis algorithms, fluorescent probes put scalable, information-rich, and actionable data within reach of nearly any drug discovery or quantitative biology team. 

The intelligent use of fluorescent ligands and advanced multiplexed imaging unlocks data fidelity, reduces operational barriers, and streamlines routine screening. By partnering with specialists in probe design, multiplexed imaging, and assay optimization, you can future-proof your high-content screening in drug discovery and drive projects from ideation to clinical impact.

Figure 2. CB2 expressing HEK cells labelled with Celtarys fluorescent ligand CELT-331

At Celtarys, we translate that vision into action through next-generation fluorescent ligand-based HCS solutions, including custom assays and ready-to-use kits that bring the power of ligand-driven imaging directly to your lab. Our cannabinoid-focused portfolio combines scientific rigor with a hands-on, collaborative approach, offering continuous support throughout your experiments and delivering results in record time.

If you’re ready to simplify your high-content screening workflow and gain deeper, faster insights from your assays, get in touch today to request a quote and discover how our research team can accelerate your next discovery campaign.

References

Bray MA, Singh S, Han H, Davis CT, Borgeson B, Hartland C, Kost-Alimova M, Gustafsdottir SM, Gibson CC, Carpenter AE. Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes. Nat Protoc. 2016 Sep;11(9):1757-74. doi: 10.1038/nprot.2016.105

von Coburg E, Wedler M, Muino JM, Wolff C, Körber N, Dunst S, Liu S. Cell Painting PLUS: expanding the multiplexing capacity of Cell Painting-based phenotypic profiling using iterative staining-elution cycles. Nat Commun. 2025 Apr 24;16(1):3857. doi: 10.1038/s41467-025-58765-8

Seal S, Trapotsi MA, Spjuth O, Singh S, Carreras-Puigvert J, Greene N, Bender A, Carpenter AE. Cell Painting: a decade of discovery and innovation in cellular imaging. Nat Methods. 2025 Feb;22(2):254-268. doi: 10.1038/s41592-024-02528-8. Epub 2024 Dec 5. Erratum in: Nat Methods. 2025 Feb;22(2):447. doi: 10.1038/s41592-024-02578-y

Way GP, Sailem H, Shave S, Kasprowicz R, Carragher NO. Evolution and impact of high content imaging. SLAS Discov. 2023 Oct;28(7):292-305. doi: 10.1016/j.slasd.2023.08.009